LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today


Bioabsorbable cardiovascular valves and vessels designed to allow Endogenous Tissue Restoration.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Xeltis plus 6116 other startups.

Learn More About Xeltis

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups